FEATURED ARTICLES

ALS, MND, Lou Gehrig's disease, terminal neurodegenerative disorder-GettyImages-2243922832 ALS Researchers Use Stratification, Diverse Endpoints To Address Heterogeneity

Coya Therapeutics' Fred Grossman dives into innovative trial design elements and a novel biomarker that might better account for clinical and functional progression in Coya's ALS trial studying a dual immunomodulatory therapy.

WHITE PAPERS & CASE STUDIES

SERVICES & PRODUCTS

Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.

At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.

Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.

Why Work With AutoCruitment?

AutoCruitment is the ultimate patient recruitment solution for clinical trials. We specialize in identifying, enrolling, and supporting the most qualified patients for clinical trials through a sophisticated screening process that aligns directly with your study’s protocols.

At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.

Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.

NEWS